Official websites use .gov
A
.gov
website belongs to an official government organization in the
United States.
Secure .gov websites use HTTPS
A
lock
(
) or
https://
means you’ve safely connected to the .gov website. Share sensitive
information only on official, secure websites.
PubMed ID:
22198704
Public Release Type:
Journal
Publication Year: 2012
Affiliation: Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-8887, USA.
DOI:
https://doi.org/10.1007/s10620-011-2013-3
Authors:
Sanders C,
Murray M,
Webster JW,
Smith JP,
Hynan L,
Reisch J,
Sanders C,
Pezzia C,
Munoz S,
Reddy R,
Stravitz R,
Rossaro L,
Satyanarayana R,
Hassanein T,
Samuel G,
Dao DY,
Seremba E,
Ajmera V,
Hynan LS,
Lee WM,
Acute Liver Failure Study Group,
Lee WM,
Ostapowicz GA,
Schiødt FV,
Polson J,
Larson AM,
Davern T,
Schilsky M,
McCashland T,
Hay J,
Murray N,
Shaikh A,
Blei A,
Zaman A,
Han SH,
Fontana R,
McGuire B,
Chung RT,
Smith A,
Brown R,
Crippin J,
Harrison E,
Lalani E,
Reuben A
Studies:
Acute Liver Failure Study Group: Adult Acute Liver Failure Study
The efficacy of nucleoside(tide) analogues (NA) in the treatment of acute liver failure due to hepatitis B virus (HBV-ALF) remains controversial. We determined retrospectively the impact of NAs in a large cohort of patients with HBV-ALF.
